Acta Neuropathologica Communications

Article	Citations
Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxication	258
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease	179
Novel histotypes of sporadic Creutzfeldt–Jakob disease linked to 129MV genotype	124
Clinicopathologic features of two unrelated autopsied patients with Charcot-Marie-Tooth disease carrying MFN2 gene mutation	112
Correction to: Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas	96
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve	89
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism	83
High-grade astrocytoma with piloid features: a single-institution case series and literature review	69
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation	67
Tau seeding in cases of multiple sclerosis	66
A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons	62
NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells	60
DNA methylation as a contributor to dysregulation of STX6 and other frontotemporal Lobar degeneration genetic risk-associated loci	53
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value	53
Exogenous interleukin 33 enhances the brain’s lymphatic drainage and toxic protein clearance in acute traumatic brain injury mice	51
Histomorphological variations in progressive multifocal leukoencephalopathy correlated with JCV replication in brain lesions: insights from 91 patients	50
The genomic alterations in glioblastoma influence the levels of CSF metabolites	48
Pleomorphic xanthoastrocytoma in the multiverse of epigenomics: is it time to recognize the variants?	48
Correction: Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	47
Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination	46
Single-cell spatial proteomic imaging for human neuropathology	45
SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature	45
Neutrophil infiltration and microglial shifts in sepsis induced preterm brain injury: pathological insights	45
Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia	44
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI	42

Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases	42
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients	42
Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data	42
Mical modulates Tau toxicity via cysteine oxidation in vivo	42
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids	42
Low-intensity open-field blast exposure effects on neurovascular unit ultrastructure in mice	41
Therapeutic potential of NGF-enriched extracellular vesicles in modulating neuroinflammation and enhancing peripheral nerve remyelination	41
Axonal autophagic vesicle transport in the rat optic nerve in vivo under normal conditions and during acute axonal degeneration	41
A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma	41
Clinical and functional characterization of a long survivor congenital titinopathy patient with a novel metatranscript-only titin variant	40
Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion	40
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors	39
Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau	39
Facilitated α-synuclein oligomer sharing among glial cells by a centrally acting connexin inhibitor attenuates a rapidly progressive multiple system atrophy-cerebellar type model by reducing the neuro	39
ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics	39
Accurate detection of pathologic α-synuclein in CSF, skin, olfactory mucosa, and urine with a uniform seeding amplification assay	37
A microdeletion event at 19q13.43 in IDH-mutant astrocytomas is strongly correlated with MYC overexpression	37
Single-cell transcriptome sequencing reveals new epithelial-stromal associated mesenchymal-like subsets in recurrent gliomas	37
Clinical and inflammatory factors associated with the extent of resection in primary, sporadic vestibular schwannomas: A retrospective study	36
Cerebellar granule neurons induce Cyclin D1 before the onset of motor symptoms in Huntington’s disease mice	36
ROS-regulated SUR1-TRPM4 drives persistent activation of NLRP3 inflammasome in microglia after whole-brain radiation	36
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma	35
Differential vulnerability of hippocampal CA3-CA1 synapses to Aβ	34
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders	34
Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology	34
Age-dependent interactions of APOE isoform 4 and Alzheimer’s disease neuropathology: findings from the NACC	34
Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2	34
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s	33
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease	33
A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report	33
Differential vulnerability of the dentate gyrus to tauopathies in dementias	33
Oedematic-atrophic astrocytes in hepatic encephalopathy	33
Correction to: Interplay between androgen and CXCR4 chemokine signaling in myelin repair	32
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease	31
The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies	31
Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis	31
Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis	30
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model	30
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement	30
Enhancing mitosis quantification and detection in meningiomas with computational digital pathology	30
MANF protein expression is upregulated in immune cells in the ischemic human brain and systemic recombinant MANF delivery in rat ischemic stroke model demonstrates anti-inflammatory effects	29
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease	29
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration	29
Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome	29
Establishment of a patient-derived 3D in vitro meningioma model in xeno-free hydrogel for clinical applications	29
Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei	29
Regional vulnerability of brain white matter in vanishing white matter	28
Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds	28
DNA methylation profiling from cerebrospinal fluid as a diagnostic tool for pineoblastoma	28
Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling	28

Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration	28
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome	28
Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cells	28
Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations	28
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma	27
Myelin in Alzheimer’s disease: culprit or bystander?	27
Hydrogen peroxide induced by nerve injury promotes axon regeneration via connective tissue growth factor	27
Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration	27
Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis	27
Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs	27
Immune stimulation recruits a subset of pro-regenerative macrophages to the retina that promotes axonal regrowth of injured neurons	27
Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology	26
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis	26
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils	26
A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin	26
Retraction Note: Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated with improvement in cognitive fun	26
Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes	25
Correction: Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	25
Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy b	25
Unveiling the intricate dynamics of the interplay between triple-negative breast cancer cells and the blood-brain barrier endothelium	25
Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas	24
Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction	24
Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded prote	24
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models	24
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson’s disease	24
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice	24
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist	24
Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model	24
Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment	24
Structural and functional studies of the VAPB-PTPIP51 ER-mitochondria tethering proteins in neurodegenerative diseases	24
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation	24
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B	24
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization	23
Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias	23
Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	23
Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity	23
APOE-ε4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology	23
Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tangles	23
Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms	22
MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy	22
Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates Aβ accumulation	22
Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predile	22
Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelination	22
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors	21
Zika virus vertical transmission in interferon receptor1-antagonized Rag1−/− mice results in postnatal brain abnormalities and clinical disease	21
Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	21
Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis	21
Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects	21
Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice	20
Upregulation of carbonic anhydrase 1 beneficial for depressive disorder	20
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma	20
Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement	20
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective	20
Distinct forebrain regions define a dichotomous astrocytic profile in multiple system atrophy	19
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord	19
De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathy	19
Activated alpha 9 integrin expression enables sensory pathway reconstruction after spinal cord injury	19
Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastoma	19
Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions	19
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors	19
Progesterone receptor distribution in the human hypothalamus and its association with suicide	19
H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma	19
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice	19
Imaging features and consideration of progression pattern of diffuse hemispheric gliomas, H3 G34-mutant	19
Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	19
BCKDK loss impairs mitochondrial Complex I activity and drives alpha-synuclein aggregation in models of Parkinson’s disease	18
Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model	18
Operationalizing postmortem pathology-MRI association studies in Alzheimer’s disease and related disorders with MRI-guided histology sampling	18
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease	18
Targeting NAD + biosynthesis suppresses TGF-β1/Smads/RAB26 axis and potentiates cisplatin cytotoxicity in non-small cell lung cancer brain metastasis	18
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome	18
Spatio-temporal dynamics of microglia phenotype in human and murine cSVD: impact of acute and chronic hypertensive states	18
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays	18
Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer’s disease pathology in the 5xFAD mouse	17
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease	17
Current molecular understanding of central nervous system schwannomas	17
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis	17
Machine learning modeling of genome-wide copy number alteration signatures reliably predicts IDH mutational status in adult diffuse glioma	17
Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)	17
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4	17

Single-nucleus multi-omics of Parkinson’s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks	17
Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	17
Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two cases	17
TDP43 pathology in chronic traumatic encephalopathy retinas	17
A patient-derived cell model for malignant transformation in IDH-mutant glioma	17
Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells	17
Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R/4R tau aggregation	16
Cortical microvascular raspberries and ageing: an independent but not exclusive relationship	16
DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment	16
TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice	16
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma	16
Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease	16
The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease	15
TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis	15
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice	15
Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!	15
Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue	15
The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation	15
Cryo-EM studies of amyloid-β fibrils from human and murine brains carrying the Uppsala APP mutation (Δ690–695)	15
Transcription factor-based classification of pituitary adenomas / PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases	15
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease	15
Impaired SorLA maturation and trafficking as a new mechanism for SORL1 missense variants in Alzheimer disease	15
The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration	15
Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke	15
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition	15
Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease	15
Trem2-deficiency aggravates and accelerates age-related myelin degeneration	15
Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence	15
Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis	15
Plasma proteome profiling identifies changes associated to AD but not to FTD	14
Acquired neuropathology and its associations with key patterns of placental pathology	14
Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse	14
Correction: Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas	14
Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN	14
Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies	14
PRC2 disruption in cerebellar progenitors produces cerebellar hypoplasia and aberrant myoid differentiation without blocking medulloblastoma growth	14
The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects	14
Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A	14
Wolfram syndrome 1b mutation suppresses Mauthner-cell axon regeneration via ER stress signal pathway	14
Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic	14
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	14
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling	14
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis	14
Beyond the brain: early autonomic dysfunction in Alzheimer’s disease	14
On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells	14
Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer’s disease mouse model	14
Publisher Correction: Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development an	14
The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies	14
Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease	14
Lack of junctional adhesion molecule (JAM)-B traps CD8 T cells in CNS border zones and ameliorates autoimmune neuroinflammation	14
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion	13
Amygdala granular fuzzy astrocytes are independently associated with both LATE neuropathologic change and argyrophilic grains: a study of Japanese series with a low to moderate Braak stage	13
Interface astrogliosis in contact sport head impacts and military blast exposure	13
APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study	13
CNS embryonal tumour with concomitant novel BRD4::CTRC1 fusion and BCOR internal tandem duplication – evidence for synergism and non-mutually exclusive alterations in CNS embryonal tumours	13
Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies	13
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort	13
Temporal patterns of microglial activation in white matter following experimental mild traumatic brain injury: a systematic literature review	13
Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing	13
Alcohol-induced damage to the fimbria/fornix reduces hippocampal-prefrontal cortex connection during early abstinence	13
High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	13
AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD	13
Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer’s disease	13
Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cells	13
RNF168 dephosphorylation ameliorates cognitive decline in Aβ-based mouse models of Alzheimer’s disease	13
LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease	13
Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer’s disease and experimental chronic cerebral hypoperfusion	13
Correction to: Dynamic profiling of medulloblastoma surfaceome	13
Brain macrophages and pial fibroblasts promote inflammation in a hypomyelination model	13
Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease	13
Partial normalization of hippocampal oscillatory activity during sleep in TgF344-AD rats coincides with increased cholinergic synapses at early-plaque stage of Alzheimer’s disease	12
Cerebrovascular p16INK4A expression induces cerebral small vessel disease-related phenotypes	12
Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research	12
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19	12
The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias	12
Genomic and immune profiling of breast cancer brain metastases	12
Divergent and convergent TMEM106B pathology in murine models of neurodegeneration and human disease	12
Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis	12
Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas	12
Acute minocycline administration reduces brain injury and improves long-term functional outcomes after delayed hypoxemia following traumatic brain injury	12
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators	12
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection	12
Pathological ultrastructural alterations of myelinated axons in normal appearing white matter in progressive multiple sclerosis	12
Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro	12
A mouse model of stereotactic radiosurgery-induced neuroinflammation and blood-brain barrier compromise	12
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation	12
High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumors	12
Pharmacological inhibition of SPAK-NKCC1 complex attenuates astrogliosis and restores cerebral blood flow in a mouse model of VCID	12
Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes	12
Adequate post-ischemic reperfusion of the mouse brain requires endothelial NFAT5	12
Glioblastoma CD105+ cells define a SOX2− cancer stem cell-like subpopulation in the pre-invasive niche	12
Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease	11
A single mild juvenile TBI in male mice leads to regional brain tissue abnormalities at 12 months of age that correlate with cognitive impairment at the middle age	11
Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer’s disease	11
Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology	11